AMYOTROPHIC LATERAL SCLEROSIS 1
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
Mutant dynactin in motor neuron disease.
|
12627231 |
2003 |
AMYOTROPHIC LATERAL SCLEROSIS 1
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genetic heterogeneity of motor neuropathies.
|
28251916 |
2017 |
AMYOTROPHIC LATERAL SCLEROSIS 1
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
Lysosomal proliferation and distal degeneration in motor neurons expressing the G59S mutation in the p150Glued subunit of dynactin.
|
18364389 |
2008 |
AMYOTROPHIC LATERAL SCLEROSIS 1
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
Distal hereditary motor neuropathy type 7B with Dynactin 1 mutation.
|
27573046 |
2016 |
AMYOTROPHIC LATERAL SCLEROSIS 1
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Alteration of Motor Protein Expression Involved in Bidirectional Transport in Peripheral Blood Mononuclear Cells of Patients with Amyotrophic Lateral Sclerosis.
|
26954557 |
2016 |
AMYOTROPHIC LATERAL SCLEROSIS 1
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS.
|
15326253 |
2004 |
AMYOTROPHIC LATERAL SCLEROSIS 1
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
DCTN1 mutations in Perry syndrome.
|
19136952 |
2009 |
AMYOTROPHIC LATERAL SCLEROSIS 1
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD.
|
16240349 |
2005 |
AMYOTROPHIC LATERAL SCLEROSIS 1
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
The dynactin p150 subunit: cell biology studies of sequence changes found in ALS/MND and Parkinsonian syndromes.
|
23143281 |
2013 |
AMYOTROPHIC LATERAL SCLEROSIS 1
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
The G59S mutation in p150(glued) causes dysfunction of dynactin in mice.
|
18094236 |
2007 |
Amyotrophic Lateral Sclerosis, Familial
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Amyotrophic Lateral Sclerosis, Sporadic
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
DCTN1 gene analysis in Chinese patients with sporadic amyotrophic lateral sclerosis.
|
28792508 |
2017 |
Amyotrophic Lateral Sclerosis, Sporadic
|
0.310 |
Biomarker
|
disease |
CTD_human |
|
|
|
AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO
|
0.100 |
SusceptibilityMutation
|
phenotype |
CLINVAR |
|
|
|
Anxiety
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Apathy
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Atypical Spitz Nevus
|
0.010 |
Biomarker
|
disease |
BEFREE |
STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion.
|
26062823 |
2015 |
Autosomal Dominant Juvenile Parkinson Disease
|
0.300 |
Biomarker
|
disease |
CTD_human |
DCTN1 mutations in Perry syndrome.
|
19136952 |
2009 |
Autosomal Dominant Parkinsonism
|
0.320 |
Biomarker
|
disease |
CTD_human |
DCTN1 mutations in Perry syndrome.
|
19136952 |
2009 |
Autosomal Dominant Parkinsonism
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Perry syndrome is a rare form of autosomal dominant Parkinsonism with respiratory failure recently defined as being due to mutations in the DCTN1 gene.
|
20437543 |
2010 |
Autosomal Dominant Parkinsonism
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Perry syndrome (PS) caused by DCTN1 gene mutation is clinically characterized by autosomal dominant parkinsonism, depression, severe weight loss, and hypoventilation.
|
24484619 |
2014 |
Autosomal Recessive Parkinsonism
|
0.300 |
Biomarker
|
disease |
CTD_human |
DCTN1 mutations in Perry syndrome.
|
19136952 |
2009 |
Behavioral syndrome associated with physiological disturbance and physical factors
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Perry syndrome due to the DCTN1 G71R mutation: a distinctive levodopa responsive disorder with behavioral syndrome, vertical gaze palsy, and respiratory failure.
|
20437543 |
2010 |
Behavioral variant of frontotemporal dementia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Our study demonstrates that DCTN1 mutations should be searched for in patients with clinical PSP-like phenotypes and a behavioral variant of frontotemporal dementia, especially when a familial history of dementia, psychiatric disturbances, associated parkinsonism, or an autosomal dominant disorder is present.
|
24343258 |
2014 |
Bradykinesia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|